DemTect registered - effective to asses MCI and dementia - validation study of the Polish language version

• Published in: Aging & mental health Vol. 20; no. 5; pp. 510 - 516
• Main Authors: Wojtynska, R, Szczesniak, D
• Format: Journal Article
• Language: English
• Published: 03-05-2016
• ISSN: 1360-7863; 1364-6915
• DOI: 10.1080/13607863.2015.1023763

Objectives: To validate DemTect registered , a highly sensitive psychometric screening tool - designed to identify patients with mild cognitive impairment (MCI) and patients with dementia (AD). Method: A prospective cohort/cross-sectional study was designed. The data were collected from a group of 224 subjects, including 85 patients with MCI, 109 with Alzheimer's disease (AD) and 30 healthy control (HC) subjects. All subjects underwent a detailed neuropsychological assessment including CT, the assessment of biological parameters and a psychometric examination using DemTect registered , MMSE, TYM, CDT and FAS. Results: Subjects ranged in age from 55 to 94 years, with a mean age of 71.42 plus or minus 9.86 years. Classification rates of DemTect registered were superior for both the MCI and AD groups compared with the MMSE, with high sensitivities of 90% (cut-off less than or equal to 15) and 96.8% (cut-off < 10), respectively. The DemTect registered Polish language version proved to be independent of age and education level. Conclusion: The Polish language version of the DemTect registered scale is easy to administer. It may be seen as a superior cognitive screening tool in day-to-day practice as it achieves more accurate differentiation between HC/MCI/AD compared with MMSE.